title: Burkholderia pseudomallei - a rare cause for septic arthritis.
authors.forename: Raju
authors.initials: R
authors.lastname: Karuppal
authors.forename: Anwar
authors.initials: A
authors.lastname: Marthya
authors.forename: Sudarsana
authors.initials: S
authors.lastname: Justus
authors.forename: Chathoth Meethal
authors.initials: CM
authors.lastname: Kumaran
authors.forename: Gopinathan
authors.initials: G
authors.lastname: Padinjareyil
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D001854:Bone Marrow Cells / Q000382:microbiology / Q000473:pathology; D016957:Burkholderia pseudomallei / Q000302:isolation & purification / Q000472:pathogenicity* / Q000502:physiology; D002442:Ceftazidime / Q000627:therapeutic use; D002478:Cells, Cultured; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007275:Injections, Intravenous; D007719:Knee Joint / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008554:Melioidosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D008826:Microbial Sensitivity Tests; D016059:Range of Motion, Articular; D013582:Synovial Fluid / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002442:Ceftazidime; D004318:Doxycycline